These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9636478)

  • 1. Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients.
    Schütz E; Armstrong VW; Shipkova M; Weber L; Niedmann PD; Lammersdorf T; Wiesel M; Mandelbaum A; Zimmerhackl LB; Mehls O; Tönshoff B; Oellerich M
    Transplant Proc; 1998 Jun; 30(4):1182-4. PubMed ID: 9636478
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients.
    Budde K; Braun KP; Glander P; Böhler T; Hambach P; Fritsche L; Waiser J; Mai I; Neumayer HH
    Transplant Proc; 2002 Aug; 34(5):1748-50. PubMed ID: 12176561
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of mycophenolic acid after renal transplantation.
    Wollenberg K; Krumme B; Schollmeyer P; Kirste G
    Transplant Proc; 1998 Aug; 30(5):2237-9. PubMed ID: 9723455
    [No Abstract]   [Full Text] [Related]  

  • 4. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
    Engelbertink R; Smak Gregoor P; Hesse C; IJzermans J; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2983-4. PubMed ID: 12431677
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation.
    Wollenberg K; Krumme B; Pisarski P; Schollmeyer P; Kirste G
    Transplant Proc; 1998 Dec; 30(8):4090-1. PubMed ID: 9865307
    [No Abstract]   [Full Text] [Related]  

  • 6. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite.
    Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Wieland E; Oellerich M
    Transplant Proc; 1999; 31(1-2):1135-7. PubMed ID: 10083508
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients.
    Aigrain EJ; Shaghaghi EK; Baudouin V; Popon M; Loirat C
    Transplant Proc; 2000 Mar; 32(2):388-90. PubMed ID: 10715449
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic study of mycophenolate mofetil in Asian renal transplant recipients.
    Yeung S; Tong KL; Tsang WK; Chan HW; Chan AY
    Transplant Proc; 2000 Nov; 32(7):1753-4. PubMed ID: 11119920
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
    Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
    Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring of mycophenolic acid in pediatric renal transplant recipients.
    Armstrong VW; Shipkova M; Schütz E; Weber L; Tönshoff B; Oellerich M;
    Transplant Proc; 2001; 33(1-2):1040-3. PubMed ID: 11267182
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.
    Mohammadpur AH; Nazemian F; Abtahi B; Naghibi M
    Exp Clin Transplant; 2008 Dec; 6(4):276-81. PubMed ID: 19338489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
    Schütz E; Shipkova M; Armstrong VW; Niedmann PD; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M
    Transplant Proc; 1998 Jun; 30(4):1185-7. PubMed ID: 9636479
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic drug monitoring of total and free mycophenolic acid (MPA) and limited sampling strategy for determination of MPA-AUC in paediatric renal transplant recipients. The German Study Group on Mycophenolate Mofetil (MMF) Therapy.
    Weber LT; Schütz E; Lamersdorf T; Shipkova M; Niedmann PD; Oellerich M; Zimmerhackl LB; Staskewitz A; Mehls O; Armstrong VW; Tönshoff B
    Nephrol Dial Transplant; 1999; 14 Suppl 4():34-5. PubMed ID: 10463209
    [No Abstract]   [Full Text] [Related]  

  • 14. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial.
    Mudge DW; Atcheson B; Taylor PJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Nicol DL; Pillans PI; Johnson DW
    Transplantation; 2004 Jan; 77(2):206-9. PubMed ID: 14742982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid and mycophenolic acid glucuronide trough levels after renal transplantation.
    Behrend M; Lueck R; Pichlmayr R
    Transplant Proc; 1997 Nov; 29(7):2936-8. PubMed ID: 9365620
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
    Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H
    Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
    Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
    Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
    de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
    Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.